Sun Pharma Introduces Cognitgrey, a Nutritional Supplement for Children's Cognitive Development
With growing focus on cognitive nutrition among children, Sun Pharma has announced the launch of Cognitgrey, a novel nutritional supplement formulated to support memory, concentration, reading, and learning in children.
Cognitgrey is an FSSAI-approved nutritional supplement. Each 10 mL contains DHA 300 mg, choline 75 mg, lutein 5 mg, zeaxanthin 1 mg, fructooligosaccharides 2 g, iron 2.25 mg, and vitamin B12 0.05 mcg, with a recommended dosage of 10 ml twice daily. It is available in a 200 ml bottle and contains algae-derived DHA, with no added colour, in a sugar-free orange-flavoured formulation.
Cognitgrey supports the comprehensive learning pathway by enhancing visual input through lutein and zeaxanthin in an optimal 5:1 ratio (lutein 10 mg and zeaxanthin 2 mg) supporting neural processing with high-dose DHA and choline, and contributing to cognition. It also contains iron and vitamin B12 in prophylactic quantities and is enriched with FOS to support nutrient absorption.
Studies on lutein and zeaxanthin have shown improvements in macular pigment optical density, serum lutein, zeaxanthin, and BDNF(brain-derived neurotrophic factor) levels, along with better visual and cognitive performance and reduced eye strain and fatigue in children receiving lutein and zeaxanthin (LZ) supplementation1. The DOLAB study also suggested that DHA 600 mg/day supplementation may help improve reading and behaviour in healthy but underperforming school-aged children2.
Commenting on the launch, Mr. Ramakrishna BVR, Sr. GM – Stanlife, Sun Pharma, said, “While the first 1,000 days of life are widely recognised as the foundation for healthy growth and development, the period beyond the first 1,000 days is often overlooked. This “Beyond the First 1,000 Days” phase presents a valuable opportunity to continue to support brain development, learning, cognitive function, and school readiness. Providing the right nutrition during these formative years is essential to support the developing brain and unlock their learning potential. Recognising this important yet under-addressed nutritional need beyond the first 1,000 days, we have introduced Cognitgrey—a comprehensive multi-nutrient formulation designed to support the cognitive development pathway, from visual input and neural processing to cognition.”
The launch comes at a time when cognitive nutrition is receiving greater national attention, with the Government of India’s Poshan Pakhwada 2026 theme, “Maximising Brain Development in the First Six Years of Life,” placing early nutrition at the centre of its awareness campaign3.
Sun Pharma is India’s largest pharmaceutical company, headquartered in Mumbai. It manufactures and markets a wide range of pharmaceutical formulations across more than 100 countries.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.